Health Catalyst, Inc., a healthcare intelligence company designed to accelerate measurable improvement for health systems, recently announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026. Having used the net cash proceeds plus cash on hand to fully repay and terminate all of its obligations under its credit facility, Health Catalyst plans to focus its capital and its people on its highest-conviction technology, designed for the pressures defining the health system agenda: managing cost, advancing clinical quality, and earning consumer loyalty, all at once.
The Company plans to focus its product roadmap on delivering intelligence products that combine a client’s data with the Company’s USD 2.8 billion in documented outcomes to identify what can drive improvement for that client, then help carry that change through the organization. Organizations don’t change; people do, so the Company is investing deliberately in its intelligence products to bring each plan down to what an individual can do differently, which is what Health Catalyst believes makes improvement last.
The transaction included USD 147 million in total cash consideration for Health Catalyst, subject to customary adjustments. The Company used those proceeds plus cash on hand to fully repay and retire its obligations under its credit facility, which eliminates approximately USD 19 million in annual interest expense on a GAAP basis, based upon annualizing the first half of 2026. The Company believes this strengthened balance sheet will provide financial flexibility to invest decisively in its core strategy.
“We’re excited about where we are headed,” said Ben Albert, CEO of Health Catalyst. “To us, powerful analytics are essential, and our expertise is built on 18 years of what actually works. What comes next is the part that we believe matters most: pairing that with knowing where to act, in what order, and with what impact, and the support to help make change stick. That’s the problem we’re working to solve, and we believe we are well-positioned to solve it.”
Health Catalyst is focusing on pairing 18 years of proprietary healthcare improvement data and analytics with AI-driven products and the human expertise to put it to work. With the divestiture behind it, Health Catalyst is investing in the intelligence layer the proprietary data, benchmarks, and expertise that the Company believes set it apart—which is at the core of the products it’s developing. These are designed to deepen the advantage that turns Health Catalyst’s data into results. Data is the foundation. Intelligence is what the Company is building now, with its advantage of 18 years of proprietary healthcare improvement data: USD 2.8 billion in documented outcomes, across more than 380 client improvement case studies.
Read Similar News:
XRP Healthcare Expands its Healthcare Services to the African Continent
Swisslog Healthcare to Showcase Pharmacy Automation Technology in California
Kindthread unveils White Cross CRFT: a new line of healthcare apparel line
